We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information on good laboratory, manufacturing and distribution practice, good pharmacovigilance practice (GPvP), out-of-specification investigations, inspection metrics and fees.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
British Pharmacopoeia (BP) provides official standards for pharmaceutical substances and medicinal products. British Pharmacopoeia Commission is an advisory non-departmental public body, sponsored by the Department of Health and Social Care .
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Check what side effects people have reported when they've taken a medicine.
Pharmacovigilance system requirements
Guidance for the veterinary pharmaceutical industry on the production and submission of the Summary of Product Characteristics (SPCs) and product literature mock-ups.
Information regarding malaria incidents, announcements and guidance amendments from the UKHSA Advisory Committee on Malaria Prevention (ACMP).
Information for healthcare professionals and the public about the Pfizer/BioNTech vaccine.
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
medac GmbH (t/a medac Pharma LLP) is recalling the products and respective batches in this notification due to particles detected during long-term stability tests.
Co-proxamol's phased withdrawal period lasts until the end of 2007 to enable patients to move to suitable alternatives.
Guidance for industry on flexible approaches we are taking on good distribution practices.
A form of IP that extends the protection of patented active ingredients present in pharmaceutical or plant protection products.
Healthcare professionals prescribing montelukast should be alert to the risk of neuropsychiatric reactions in all patients including children and adolescents. Reported neuropsychiatric reactions include sleep disorders, hallucinations, anxiety and depression, as well as changes in behaviour and mood. Healthcare professionals...
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).